Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-14

Clinical Trial Update: A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic Astigmatism [NA]

View source ↗

Summary

Completed clinical trial evaluating the Technolas TENEO 317 Model 2 Excimer Laser for treating myopia and myopic astigmatism; results were posted in June 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Technolas TENEO 317 Model 2 Excimer Laser

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Myopia, Myopic Astigmatism | NA | Status: COMPLETED | Results posted: 2024-06-14